Product Wiki · Recalls · U.S. FDA — Food Enforcement

MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK… — recall H-1128-2026

U.S. FDA — Food Enforcement · United States · 2026-05-24 · Class I

As described by U.S. FDA — Food Enforcement: MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK RELEASE VEGGIE CAPSULE, 100% PURE, 350 MG PER CAPSULE, SUPPLEMENT FACTS MORINGA POWDER 1050 mg, Ingredients: 100% Pure Moringa Leaf Powder (Moringa Oleifera), MANUFACTURED IN USA AND Marketed by: MOGO MIRINGA LLC, PO BOX 32066 Saint L

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Food Enforcement
Recall identifier
H-1128-2026
Date of alert
2026-05-24
Country / jurisdiction
United States
Risk level
Class I
Notice type
recall
Brand
MOGO Moringa LLC
Product category
food
Product type
Food
Recall status
Ongoing — the recall is still in progress
Initiated by
Voluntary: Firm initiated
Distribution
Products were sold nationwide via ecommerce (Amazon, Ebay, Etsy, and mogomiranga.com)
🔴 Serious hazard — Reported risk: Product may be contaminated with Salmonella Typhimurium
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from U.S. FDA — Food Enforcement →

Primary source: https://api.fda.gov/food/enforcement.json?search=recall_number:%22H-1128-2026%22

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.